MedPredict launches AI health app & diagnostic kiosks

MedPredict has launched MediElaj, an artificial intelligence-based healthcare app and diagnostic kiosk platform in India, aimed at communities in urban, semi-urban and rural areas.

MediElaj combines a mobile application with smart kiosks that offer diagnostic screening outside traditional hospital settings. Each kiosk can conduct more than 30 tests, including ECG, SpO2 monitoring and vital signs assessment, using a mix of invasive and non-invasive procedures.

The app has recorded more than 100,000 downloads, while its artificial intelligence diagnostic engine operates at an efficiency rate of more than 90%, according to MedPredict.

The rollout reflects a wider push by health technology companies to extend screening and early diagnosis beyond large hospitals and metropolitan centres. MedPredict's kiosk model is intended for neighbourhoods, workplaces, Tier-2 and Tier-3 cities, government health centres and private community clinics.

Early pilot data points to local demand for the service. A community centre kiosk has completed more than 200 diagnoses and carried out more than 350 non-invasive tests, the company said.

Access model

MediElaj is positioned as a preventive care and screening service for areas where diagnostic access can be limited by distance, cost and pressure on clinical infrastructure. The app also offers artificial intelligence-assisted symptom analysis, wellness tools and patient support services, linking digital triage with in-person testing.

Debjit Patra, Founder & Chairman, MediElaj, outlined the company's position on the launch.

"MediElaj is built to transform the very foundation of public healthcare by strengthening availability, affordability, scalability, and equity through breakthrough AI technology. We believe this will drive a paradigm shift in diagnostics and screening across the global healthcare ecosystem. Our goal is to enable a systemic transformation in healthcare delivery at scale, both in India and globally," said Patra.

MedPredict has signed memorandums of understanding with hospitals and colleges for collaborative research and healthcare innovation. Discussions are also under way with the governments of two western Indian markets for pilot healthcare programmes, subject to clinical validation.

Compliance focus

The company said it has obtained ISO 13485 and ISO 14791 certifications. It has also secured test and commercial licences for Indian operations under software as a medical device, ISO and Digital Personal Data Protection Act frameworks.

Those details are likely to draw attention in a market where health technology businesses face scrutiny over clinical evidence, data use and regulatory oversight. MedPredict said it is pursuing broader international regulatory readiness alongside work in overseas markets.

India's digital health sector has attracted growing interest as companies try to bridge gaps in access to doctors, diagnostics and preventive care, particularly outside major cities. Kiosk-based healthcare has emerged as one route to bring tests and screening into community settings, though adoption depends on pricing, reliability, local partnerships and clinical trust.

MedPredict said MediElaj is designed to serve underserved populations and widen the reach of early diagnosis. The launch is part of an effort to build a connected healthcare model linking software-based assessment with physical testing at the local level.

The platform enters a competitive market for digital triage, remote screening and community diagnostics, where operators are trying to show that lower-cost access points can still meet medical, technical and privacy standards. MedPredict said its model is built around affordable testing delivered closer to where patients live and work.

For now, the clearest operational measure disclosed is activity at a single community centre kiosk, where more than 200 diagnoses and over 350 non-invasive tests have been completed.